The role of regulatory cells CD4+CD25+ in the development of chronic infective diseases

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk

Volumn , Issue 9-10, 2006, Pages 24-29

  Vorobyov, A A ^a   Bykovskaya, S N ^a   Pashkov, Ye P ^a   Bykov, A S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33751563173     PISSN: 08696047     EISSN: 24143545     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Levings M. K., Roncarolo M. G. T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. J. Allergy Clin. Immunol. 2000; 106: S109-S112.
2. - regulatory T cells. J. Immunol. 1998; 161: 5193-5202.
3. + T cells to dexamethasone. J. Immunol. 1999; 163: 2522-2529.
4. + suppressor cell and its mechanisms of action. J. Exp. Med. 1990; 171: 141-157.
5. Sakaguchi S., Sakaguchi N., Asano M. et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995; 155: 1151-1164.
6. Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 1996; 184: 387-396.
7. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 2002; 168: 5979-5983.
8. - cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 2004; 172: 5213-5221.
9. Wood K. J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 2003; 3: 199-210.
10. Umetsu D. T., Akbari O., Dekruyff R. H. Regulatory T cells control the development of allergic disease and asthma. J. Allergy Clin. Immunol. 2003; 112: 480-487.
11. Papiernik M., de Moraes M. L., Pontoux C. et al. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 1998; 10: 371-378.
12. + regulatory T cells. Nat. Immunol. 2003; 4: 330-336.
13. Grossman W. J., Verbsky J. W., Barchet W. et al. Human T regulatory cells can use the perform pathway to cause autologous target cell death. Immunity 2004; 21: 589-601.
14. Thompson C. B., Allison J. P. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997; 7: 445-450.
15. + regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. 2002; 196: 247-253.
16. Mills K. H. Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. 2004; 4: 841-855.
17. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502-507.
18. + T cell response during Listeria monocytogenes infection. J. Immunol. 2002; 168: 6382-6387.
19. + T cells and gamma interferon in the long-term control of persistent friend retrovirus infection. J. Virol. 2001; 75: 52-60.
20. + regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 2002; 169: 6298-6308.
21. Singh B., Read S., Asseman C. et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 2001; 182: 190-200.
22. + T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol. 2002; 32: 1282-1291.
23. + regulatory T cells suppress effector T cell proliferation. Clin. Immunol. 2005; 115: 3-9.
24. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2001; 2: 675-680.
25. Rock F. L., Hardiman G., Timans J. C. et al. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 1998; 95: 588-593.
26. Brightbill H. D., Libraty D. H., Krutzik S. R. et al. Host defense mechanisms triggered by microbial lipoproteins through tolllike receptors. Science 1999; 285: 732-736.
27. Hayashi F., Smith K. D., Ozinsky A. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099-1103.
28. Ulevitch R. J., Tobias P. S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 1995; 13: 437-457.
29. Caramalho I., Lopes-Carvalho T., Ostler D. et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 2003; 197: 403-411.
30. McGuirk P., Mills K. H. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 2002; 23: 450-455.
31. Ernst P. B., Takaishi H., Crowe S. E. Helicobacter pylori infection as a model for gastrointestinal immunity and chronic inflammatory diseases. Dig. Dis. Sci. 2001; 19: 104-111.
32. +CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect, and Immun. 2003; 71: 1755-1762.
33. +CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect, and Immun. 2005; 73: 523-531.
34. Netea M. G., Van Der Graaf C. A., Vonk A. G. et al. The role of toll-like receptor (TLR)2 and TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis. 2002; 185: 1483-1489.
35. Netea M. G., Van der Meer J. W., Kullberg B. J. Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol. 2004; 12: 484-488.
36. + regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J. Immunol. 2005; 174: 7147-7153.
37. Williamson W. A., Greenwood B. M. Impairment of the immune response to vaccination after acute malaria. Lancet 1978; 1: 1328-1329.
38. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502-507.
39. + regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immuniity 2005; 23: 287-296.
40. Mittrucker H. W., Kaufmann S. H. Mini-review: regulatory T cells and infection: suppression revisited. Eur. J. Immunol. 2004; 34: 306-312.
41. + regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol. 2004; 172: 4123-4132.
42. + T-cell responses against herpes simplex virus type 1. J. Virol. 2004; 78: 13082-13089.
43. + T cells in chronic hepatitis C virus infection. J. Immunol. 2002; 169: 3447-3458.
44. + T cells during chronic hepatitis C virus infection. J. Virol. 2005; 79: 7860-7867.
45. + T cells during persistent hepatitis C virus infection. J. Virol. 2005; 79: 7852-7859.
46. Chisari F. V. Cytotoxic T cells and viral hepatitis. J. Clin. Invest. 1997; 99: 1472-1477.
47. + T cell response primed by DNA immunization. Wld J. Gastroenterol. 2005; 11: 3772-3777.
48. Miedema F. Immunological abnormalities in the natural history of HIV infection: mechanisms and clinical relevance. Immunodefic. Rev. 1992; 3: 173-193.
49. Lieberman J., Shankar P., Manjunath N., Andersson J. Dressed to kill? A review of why antiviral CDS T lymphocytes fail to prevent progressive immunodeficiency in HFV-1 infection. Blood 2001; 98: 1667-1677.
50. Eggena M. P., Barugahare B., Jones N. et al. Depletion of regulatory T cells in HIV infection is associated with immune activation. J. Immunol. 2005; 174: 4407-4414.
51. + regulatory T cells to immune status in HIV-infected patients. AIDS 2005; 19: 879-886.
52. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004; 104: 3249-3256.
53. Oswald-Richter K., Grill S. M., Shariat N. et al. HIV infection of naturally occurring and genetically reprogramrned human regulatory T-cells. PLoS Biol. 2004; 2: E198.
54. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 2004; 78: 2454-2459.
55. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 2004; 200: 331-343.
56. + T cells can prevent murine AIDS progression. J. Immunol. 2004; 172: 4917-4925.
57. + regulatory T cells induced by chronic retroviral infection. Proc. Natl. Acad. Sci. USA 2001; 98: 9226-9230.
58. + T cells by regulatory T cells during persistent retroviral infection. Immunity 2004; 20: 293-303.